Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted therapy for opioid use disorder
ACTRN12625001368426Phase 2Not yet recruiting
- Sponsor
- Monash University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of psilocybin in opioid use disorder (OUD) (2 arms), sponsored by Monash University. Primary endpoint: Number of days of non-prescribed opioid use in the past 30 days. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
psilocybin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on ACTRN12625001368426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001368426.